JP Morgan Chase’s Sherwin-Williams SHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100
Closed -$32.4K 7852
2025
Q4
$32.4K Buy
+100
New +$33.5K ﹤0.01% 6390
2024
Q3
Sell
-40,500
Closed -$12.1M 7650
2024
Q2
$12.1M Hold
40,500
﹤0.01% 2288
2024
Q1
$14.1M Buy
40,500
+39,100
+2,793% +$12.5M ﹤0.01% 2185
2023
Q4
$437K Hold
1,400
﹤0.01% 4886
2023
Q3
$357K Hold
1,400
﹤0.01% 4686
2023
Q2
$372K Hold
1,400
﹤0.01% 4674
2023
Q1
$315K Hold
1,400
﹤0.01% 4780
2022
Q4
$332K Buy
+1,400
New +$324K ﹤0.01% 4767
2022
Q1
Sell
-4,800
Closed -$1.69M 6962
2021
Q4
$1.69M Sell
4,800
-2,400
-33% -$776K ﹤0.01% 3982
2021
Q3
$2.01M Hold
7,200
﹤0.01% 3790
2021
Q2
$1.96M Hold
7,200
﹤0.01% 3804
2021
Q1
$1.77M Buy
+7,200
New +$1.72M ﹤0.01% 3805
2017
Q4
Sell
-72,000
Closed -$8.57M 5565
2017
Q3
$8.57M Sell
72,000
-48,000
-40% -$5.51M ﹤0.01% 2117
2017
Q2
$14M Buy
+120,000
New +$13.4M ﹤0.01% 1706

Other funds holding SHW

JP Morgan Chase's SHW Position: Q1 2026 in Review

JP Morgan Chase increased its Sherwin-Williams (SHW) stake by 40% in Q1 2026, buying an estimated $228M and bringing the position to 2,304,657 shares worth $728M. The position accounts for 0.05% of the portfolio, ranked #326.

JP Morgan Chase first reported a position in SHW in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.16B in Q4 2021. 1,688 funds tracked by Wall St. Rank hold SHW as of Q1 2026.

  • JP Morgan Chase held 2,304,657 shares of Sherwin-Williams worth $728M as of Q1 2026.
  • JP Morgan Chase bought 663,398 Sherwin-Williams shares in Q1 2026, an estimated $228M.
  • Sherwin-Williams made up 0.05% of JP Morgan Chase's portfolio in Q1 2026, its #326 holding.
  • JP Morgan Chase first reported a position in Sherwin-Williams in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Sherwin-Williams position peaked at $1.16B in Q4 2021.
  • 1,688 funds tracked by Wall St. Rank held Sherwin-Williams as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.